Latent Phase Membrane Stripping for Caesarean Section Reduction
Launched by RICARDO A GUTIERREZ RAMIREZ, MD, MSC, FACOG · Jan 30, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a method called membrane stripping to see if it can help reduce the number of cesarean sections during childbirth. Cesarean sections are surgeries to deliver a baby, and in some places, they happen quite often, leading to risks for mothers and babies. The researchers hope that by using a specific technique during the early stages of labor, they can make it easier for women to have vaginal births instead of cesarean deliveries.
To participate in the study, women must be at least 37 weeks pregnant with one baby and have a Bishop's score of more than 7, which indicates that their body is ready for labor. Participants also need to be first-time mothers and cannot have certain health issues or previous surgeries that might complicate vaginal delivery. Those who join the study will be asked to follow specific procedures and stay available for the duration of the trial. This research is important because it aims to improve the safety and outcomes of childbirth for mothers and their babies.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Submission of a signed and dated informed consent form.
- • Declared willingness to comply with all study procedures and availability for the duration of the study.
- • nulliparous
- • woman with singleton pregnancy at 37 weeks or more
- • integral membranes
- • cephalic presentation
- • Bishop's score greater than 7
- • No contraindication for vaginal delivery
- Exclusion Criteria:
- • Previous uterine surgery
- • Maternal condition preventing vaginal delivery
- • Fetal anomaly
- • Premature rupture of membranes
- • Multiple pregnancy
- • Fetal orbit
- • Myomas
- • Maternal comorbidities such as chronic arterial hypertension, type 1, 2 and gestational diabetes, hypothyroidism, among others.
- • Anemia
About Ricardo A Gutierrez Ramirez, Md, Msc, Facog
Dr. Ricardo A. Gutierrez Ramirez, MD, MSc, FACOG, is a distinguished clinical trial sponsor and expert in the field of obstetrics and gynecology. With advanced degrees and board certification, he brings a wealth of knowledge and experience in conducting clinical research aimed at improving women's health outcomes. Dr. Gutierrez Ramirez is committed to advancing medical science through rigorous study design, ethical practices, and innovative methodologies, ensuring high-quality data that contribute to the development of effective treatments and interventions. His dedication to patient safety and scientific integrity positions him as a leading figure in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tegucigalpa, Francisco Morazán, Honduras
Tegucigalpa, , Honduras
Patients applied
Trial Officials
Ricardo A. Gutierrez Ramirez, MD, MSc.
Study Director
Universidad Nacional Autonoma de Honduras
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported